Literature DB >> 11422203

Reactive oxygen intermediates, nitrite and IFN-gamma in Indian visceral leishmaniasis.

R Kumar1, K Pai, S Sundar.   

Abstract

Reactive oxygen intermediates (ROI), nitrite and interferon-gamma (IFN-gamma) production were investigated at different times during treatment in 10 patients with visceral leishmaniasis (VL). Hydrogen peroxide (H2O2), superoxide (O2-) and IFN-gamma production by cultured monocytes from patients with active VL were significantly lower compared with the healthy controls. In contrast, nitrite levels in the supernatants from monocyte cultures of VL patients were comparable to healthy controls and increased significantly during antileishmanial therapy. On day 20 of treatment, a significant increase in the release of H2O2, O2- and IFN-gamma was observed. However, at follow-up, 4 months after the end of treatment, the production of H2O2, O2-, IFN-gamma and nitrite had declined significantly. Thus, the impairment in hydrogen peroxide and superoxide production suggests that down-regulation of these mediators may be involved in the reduced killing of parasites by monocytes of active VL patients. Furthermore, the monocytes regained respiratory burst activity as the antileishmanial therapy progressed, suggesting that an immune-based mechanism is involved in successful drug therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11422203      PMCID: PMC1906062          DOI: 10.1046/j.1365-2249.2001.01551.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

1.  Increased superoxide anion production by immunologically activated and chemically elicited macrophages.

Authors:  R B Johnston; C A Godzik; Z A Cohn
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

2.  Oxygen-dependent microbial killing by phagocytes (first of two parts).

Authors:  B M Babior
Journal:  N Engl J Med       Date:  1978-03-23       Impact factor: 91.245

3.  Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent.

Authors:  B M Babior; R S Kipnes; J T Curnutte
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

4.  Macrophage-mediated cytotoxicity: its possible role in rheumatoid arthritis.

Authors:  R Evans
Journal:  Ann N Y Acad Sci       Date:  1975-06-13       Impact factor: 5.691

5.  Anticryptococcal effect of amphotericin B is mediated through macrophage production of nitric oxide.

Authors:  M Tohyama; K Kawakami; A Saito
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

6.  A role for oxygen-dependent mechanisms in killing of Leishmania donovani tissue forms by activated macrophages.

Authors:  C G Haidaris; P F Bonventre
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

Review 7.  The immunobiology of leishmaniasis.

Authors:  R D Pearson; D A Wheeler; L H Harrison; H D Kay
Journal:  Rev Infect Dis       Date:  1983 Sep-Oct

8.  Studies on the mechanisms of macrophage activation. II. Parasite destruction in macrophages activated by supernates from concanavalin A-stimulated lymphocytes.

Authors:  Y Buchmüller; J Mauel
Journal:  J Exp Med       Date:  1979-08-01       Impact factor: 14.307

9.  Priming of macrophages for enhanced oxidative metabolism by exposure to proteolytic enzymes.

Authors:  R B Johnston; D A Chadwick; Z A Cohn
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

10.  Susceptibility of Leishmania to oxygen intermediates and killing by normal macrophages.

Authors:  H W Murray
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

View more
  8 in total

1.  Immunogenicity of the P-8 amastigote antigen in the experimental model of canine visceral leishmaniasis.

Authors:  E Carrillo; S Ahmed; K Goldsmith-Pestana; J Nieto; Y Osorio; B Travi; J Moreno; D McMahon-Pratt
Journal:  Vaccine       Date:  2006-11-10       Impact factor: 3.641

2.  Studies on the arginase, 5'-nucleotidase and lysozyme activity by monocytes from visceral leishmaniasis patients.

Authors:  Pramod Kumar; Ramesh Kumar; Haushila Pandey; Shyam Sundar; Kalpana Pai
Journal:  J Parasit Dis       Date:  2011-09-06

3.  Identification of TLR inducing Th1-responsive Leishmania donovani amastigote-specific antigens.

Authors:  Ankita Srivastava; Nisha Singh; Manish Mishra; Vinod Kumar; Jalaj K Gour; Surabhi Bajpai; Sangram Singh; Haushila P Pandey; Rakesh K Singh
Journal:  Mol Cell Biochem       Date:  2011-08-20       Impact factor: 3.396

4.  A Defective Oxidative Burst and Impaired Antigen Presentation are Hallmarks of Human Visceral Leishmaniasis.

Authors:  Susmita Roy; Debanjan Mukhopadhyay; Shibabrata Mukherjee; Susmita Ghosh; Shishir Kumar; Kumkum Sarkar; Dipankar Pal; Pratik Bhowmik; Kausik Mandal; Dolanchampa Modak; Subhasish Kamal Guha; Netai Pramanik; Rama Prosad Goswami; Bibhuti Saha; Mitali Chatterjee
Journal:  J Clin Immunol       Date:  2014-11-25       Impact factor: 8.317

5.  Quantification of Nitric Oxide and Reactive Oxygen Species in Leishmania-infected J774A.1 Macrophages as a Response to the in vitro treatment with a Natural Product Compound.

Authors:  Kalliopi Karampetsou; Olga S Koutsoni; Eleni Dotsika
Journal:  Bio Protoc       Date:  2019-12-05

6.  The involvement of TLR2 and TLR4 in cytokine and nitric oxide production in visceral leishmaniasis patients before and after treatment with anti-leishmanial drugs.

Authors:  Mariana Gatto; Mariana Miziara de Abreu; Karen Ingrid Tasca; Marjorie de Assis Golim; Laura Denise Mendes da Silva; José Cláudio Simão; Carlos Magno Castelo Branco Fortaleza; Ângela Maria Victoriano de Campos Soares; Sueli Aparecida Calvi
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

7.  Synthesis, characterization, and mechanistic studies of a gold nanoparticle-amphotericin B covalent conjugate with enhanced antileishmanial efficacy and reduced cytotoxicity.

Authors:  Pushkar Shivam; Saptarshi Mandal; Prakash Kumar; Pragya Prasanna; Saurabh Kumar; Surendra Rajit Prasad; Ashish Kumar; Prolay Das; Vahab Ali; Shubhankar Kumar Singh; Debabrata Mandal
Journal:  Int J Nanomedicine       Date:  2019-08-20

8.  Leishmania eukaryotic initiation factor (LeIF) inhibits parasite growth in murine macrophages.

Authors:  Olga Koutsoni; Mourad Barhoumi; Ikram Guizani; Eleni Dotsika
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.